Herpes simplex virus type 1 evades the effects of antibody and complement in vivo

Journal of Virology

Volumn 76, Issue 18, 2002, Pages 9232-9241

  Lubinski, John M ^a   Jiang, Ming ^a   Hook, Lauren ^a   Chang, Yueh ^a   Sarver, Chad ^a   Mastellos, Dimitrios ^a   Lambris, John D ^a   Cohen, Gary H ^a   Eisenberg, Roselyn J ^a   Friedman, Harvey M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; GLYCOPROTEIN; IMMUNOGLOBULIN G;

ANIMAL CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY SPECIFICITY; ARTICLE; CELL SPREADING; COMPLEMENT ACTIVATION; GENETIC COMPLEMENTATION; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TARGET CELL; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; COMPLEMENT SYSTEM PROTEINS; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; IMMUNOGLOBULIN FC FRAGMENTS; MICE; MICE, INBRED BALB C; MUTATION; NEUTRALIZATION TESTS; RECEPTORS, IGG; VIRAL ENVELOPE PROTEINS; VIRULENCE;

EID: 0036721332     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.18.9232-9241.2002     Document Type: Article

References (50)

1. New member of the multigene family of complement control proteins in herpesvirus saimiri
2. Neutrophil priming by cytokines and vitamin D binding protein (Gc-globulin): Impact on C5a-mediated chemotaxis, degranulation and respiratory burst
3. The acquisition of herpes simplex virus during pregnancy
4. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: Two randomized controlled trials
5. The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions
6. Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates
7. Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity
8. Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2
9. Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells
10. Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C
11. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity
12. A novel function of the herpes simplex virus type 1 Fc receptor: Participation in bipolar bridging of antiviral immunoglobulin G
13. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells
14. Virus infection of endothelial cells
15. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC
16. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade
17. A viral inhibitor of peptide transporters for antigen presentation
18. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity
19. Herpes simplex virus turns off the TAP to evade host immunity
20. Pseudorabies virus glycoprotein III derived from virions and infected cells binds to the third component of complement
21. Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host
22. gp13 (EHV-gC): A complement receptor induced by equine herpesviruses
23. Structural basis of C3b binding by glycoprotein C of herpes simplex virus
24. Innate immunity
25. Specificity of Fc receptors induced by herpes simplex virus type 1: Comparison of immunoglobulin G from different animal species
26. Herpes simplex virus gE/gI sorts nascent virions to epithelial cell junctions, promoting virus spread
27. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation
28. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus
29. A recombinant glycoprotein vaccine for herpes simplex virus type 2: Safety and immunogenicity
30. A prospective study of new infections with herpes simplex virus type 1 and type 2
31. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn., 1950 through 1982
32. Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein
33. Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI
34. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC
35. Human cytomegalovirus induces an Fc gamma receptor (Fc γR) in endothelial cells and fibroblasts that is distinct from the human cellular Fc γRs
36. Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C
37. Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions
38. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor
39. Glycoprotein gE of herpes simplex virus type 1: Effects of anti-gE on virion infectivity and on virus-induced Fc-binding receptors
40. Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein
41. Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri
42. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate and complement component C3b
43. Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus
44. Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease
45. Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease
46. New developments in the epidemiology, natural history and management of genital herpes
47. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: Results of a placebo-controlled vaccine trial
48. Viral encephalitis
49. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
50. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes